CHAPTER 1 MEDICAL AFFAIRS OUTSOURCING MARKET: METHODOLOGY AND SCOPE
1.1 MARKET SEGMENTATION & SCOPE
1.1.1 SERVICES
1.1.2 INDUSTRY
1.1.3 REGIONAL SCOPE
1.1.4 ESTIMATES AND FORECAST TIMELINE
1.2 RESEARCH METHODOLOGY
1.3 INFORMATION PROCUREMENT
1.3.1 PURCHASED DATABASE
1.3.2 GVR’S INTERNAL DATABASE
1.3.3 SECONDARY SOURCES
1.3.4 PRIMARY RESEARCH
1.3.5 DETAILS OF PRIMARY RESEARCH
1.4 INFORMATION OR DATA ANALYSIS
1.4.1 DATA ANALYSIS MODELS
1.5 MARKET FORMULATION & VALIDATION
1.6 MODEL DETAILS
1.6.1 COMMODITY FLOW ANALYSIS (MODEL 1)
1.7 LIST OF SECONDARY SOURCES
1.8 LIST OF PRIMARY SOURCES
1.9 LIST OF ABBREVIATIONS
1.10 OBJECTIVES
1.10.1 OBJECTIVE - 1
1.10.2 OBJECTIVE - 2
1.10.3 OBJECTIVE - 3
1.10.4 OBJECTIVE - 4
CHAPTER 2 MEDICAL AFFAIRS OUTSOURCING MARKET: EXECUTIVE SUMMARY
2.1 MARKET OUTLOOK
2.2 SEGMENT OUTLOOK
CHAPTER 3 MEDICAL AFFAIRS OUTSOURCING MARKET: VARIABLES, TRENDS, & SCOPE
3.1 MARKET LINEAGE OUTLOOK
3.1.1 PARENT MARKET OUTLOOK
3.1.2 ANCILLARY MARKET OUTLOOK
3.2 MARKET DYNAMICS
3.2.1 MARKET DRIVER ANALYSIS
3.2.1.1 INCREASING NUMBER OF CLINICAL TRIALS
3.2.1.2 COST-EFFECTIVENESS AND HIGH QUALITY SERVICES OFFERED BY CROS
3.2.1.3 STRINGENT REGULATORY SCENARIO
3.2.2 MARKET RESTRAINT ANALYSIS
3.2.2.1 INABILITY TO HIRE EXPERIENCED TECHNICAL STAFF
3.2.3 INDUSTRY CHALLENGES
3.2.3.1 MANAGING RELATIONSHIPS
3.2.4 COVID-19 IMPACT
3.3 MEDICAL AFFAIRS OUTSOURCING MARKET ANALYSIS TOOLS
3.3.1 PORTER’S FIVE FORCES ANALYSIS
3.3.2 PESTEL ANALYSIS
3.3.3 MAJOR DEALS & STRATEGIC ALLIANCES ANALYSIS
3.3.3.1 MERGERS AND ACQUISITIONS
3.3.3.2 COLLABORATION
3.3.3.3 PRODUCT LAUNCH
CHAPTER 4 MEDICAL AFFAIRS OUTSOURCING MARKET: BY SERVICES SEGMENT ANALYSIS
4.1 MEDICAL AFFAIRS OUTSOURCINGS: MARKET SHARE ANALYSIS, 2025 & 2033
4.2 MEDICAL WRITING & PUBLISHING
4.2.1 MEDICAL WRITING & PUBLISHING MARKET, 2018 - 2033
4.3 MEDICAL MONITORING
4.3.1 MEDICAL MONITORING MARKET, 2018 - 2033
4.4 MEDICAL SCIENCE LIAISONS (MSLS)
4.4.1 MEDICAL SCIENCE LIAISONS (MSLS) MARKET, 2018 - 2033
4.5 MEDICAL INFORMATION
4.5.1 MEDICAL INFORMATION MARKET, 2018 - 2033
4.6 OTHERS
4.6.1 OTHERS MARKET, 2018 - 2033
CHAPTER 5 MEDICAL AFFAIRS OUTSOURCING MARKET: INDUSTRY SEGMENT ANALYSIS
5.1 MEDICAL AFFAIRS OUTSOURCINGS: MARKET SHARE ANALYSIS, 2025 & 2033
5.2 PHARMACEUTICAL
5.2.1 PHARMACEUTICAL MARKET, 2018 - 2033
5.3 BIOPHARMACEUTICAL
5.3.1 BIOPHARMACEUTICAL MARKET, 2018 - 2033
5.4 MEDICAL DEVICES
5.4.1 MEDICAL DEVICES MARKET, 2018 - 2033
5.4.2 THERAPEUTIC MEDICAL DEVICES
5.4.2.1 THERAPEUTIC MEDICAL DEVICES MARKET, 2018 - 2033
5.4.3 DIAGNOSTIC MEDICAL DEVICES
5.4.3.1 DIAGNOSTIC MEDICAL DEVICES MARKET, 2018 - 2033
CHAPTER 6 MEDICAL AFFAIRS OUTSOURCING MARKET: REGIONAL ANALYSIS
6.1 MEDICAL AFFAIRS OUTSOURCING: MARKET SHARE ANALYSIS, 2025 & 2033
6.2 NORTH AMERICA
6.2.1 NORTH AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.2.2 U.S.
6.2.2.1 U.S. MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.2.3 CANADA
6.2.3.1 CANADA MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.3 EUROPE
6.3.1 EUROPE MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.3.2 UK
6.3.2.1 UK MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.3.3 GERMANY
6.3.3.1 GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.3.4 FRANCE
6.3.4.1 FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.3.5 ITALY
6.3.5.1 ITALY MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.3.6 SPAIN
6.3.6.1 SPAIN MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.3.7 SWEDEN
6.3.7.1 SWEDEN MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.3.8 DENMARK
6.3.8.1 DENMARK MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.3.9 NORWAY
6.3.9.1 NORWAY MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.4 ASIA PACIFIC
6.4.1 ASIA PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.4.2 CHINA
6.4.2.1 CHINA MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.4.3 INDIA
6.4.3.1 INDIA MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.4.4 JAPAN
6.4.4.1 JAPAN MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.4.5 AUSTRALIA
6.4.5.1 AUSTRALIA MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.4.6 SOUTH KOREA
6.4.6.1 SOUTH KOREA MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.4.7 THAILAND
6.4.7.1 THAILAND MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.5 LATIN AMERICA
6.5.1 LATIN AMERICA MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.5.2 BRAZIL
6.5.2.1 BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.5.3 MEXICO
6.5.3.1 MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.5.4 ARGENTINA
6.5.4.1 ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.6 MEA
6.6.1 MEA MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.6.2 SOUTH AFRICA
6.6.2.1 SOUTH AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.6.3 SAUDI ARABIA
6.6.3.1 SAUDI ARABIA MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.6.4 UAE
6.6.4.1 UAE MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
6.6.5 KUWAIT
6.6.5.1 KUWAIT MEDICAL AFFAIRS OUTSOURCING MARKET, 2018 - 2033
CHAPTER 7 COMPANY PROFILES
7.1 COMPANY PROFILES
7.2 ACCELL CLINICAL RESEARCH LLC
7.2.1 COMPANY OVERVIEW
7.2.2 FINANCIAL PERFORMANCE
7.2.3 SERVICE BENCHMARKING
7.2.4 STRATEGIC INITIATIVES
7.3 CHARLES RIVER LABORATORIES
7.3.1 COMPANY OVERVIEW
7.3.2 FINANCIAL PERFORMANCE
7.3.3 SERVICE BENCHMARKING
7.3.4 STRATEGIC INITIATIVES
7.4 CRITERIUM, INC.
7.4.1 COMPANY OVERVIEW
7.4.2 FINANCIAL PERFORMANCE
7.4.3 SERVICE BENCHMARKING
7.4.4 STRATEGIC INITIATIVES
7.5 GENPACT
7.5.1 COMPANY OVERVIEW
7.5.2 FINANCIAL PERFORMANCE
7.5.3 SERVICE BENCHMARKING
7.5.4 STRATEGIC INITIATIVES
7.6 ICON PLC
7.6.1 COMPANY OVERVIEW
7.6.2 FINANCIAL PERFORMANCE
7.6.3 SERVICE BENCHMARKING
7.6.4 STRATEGIC INITIATIVES
7.7 INTELLIMED HEALTHCARE SOLUTIONS
7.7.1 COMPANY OVERVIEW
7.7.2 FINANCIAL PERFORMANCE
7.7.3 SERVICE BENCHMARKING
7.7.4 STRATEGIC INITIATIVES
7.8 MEDPACE
7.8.1 COMPANY OVERVIEW
7.8.2 FINANCIAL PERFORMANCE
7.8.3 SERVICE BENCHMARKING
7.8.4 STRATEGIC INITIATIVES
7.9 PAREXEL INTERNATIONAL CORPORATION
7.9.1 COMPANY OVERVIEW
7.9.2 FINANCIAL PERFORMANCE
7.9.3 SERVICE BENCHMARKING
7.9.4 STRATEGIC INITIATIVES
7.10 PHARMAMEDIC CONSULTANCY LTD.
7.10.1 COMPANY OVERVIEW
7.10.2 FINANCIAL PERFORMANCE
7.10.3 SERVICE BENCHMARKING
7.10.4 STRATEGIC INITIATIVES
7.11 PROMEDICA INTERNATIONAL LLC
7.11.1 COMPANY OVERVIEW
7.11.2 FINANCIAL PERFORMANCE
7.11.3 SERVICE BENCHMARKING
7.11.4 STRATEGIC INITIATIVES
7.12 WUXI APP TEC
7.12.1 COMPANY OVERVIEW
7.12.2 FINANCIAL PERFORMANCE
7.12.3 SERVICE BENCHMARKING
7.12.4 STRATEGIC INITIATIVES
著作権 ©2022 無断複写・転載を禁じます
